Eagle Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments Due
Eagle Pharmaceuticals, Inc. had Operating Leases, Future Minimum Payments Due of $3.66 million as of 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDue · last filed 2020-03-02
- 2018-12-31: Operating Leases, Future Minimum Payments Due $3.66M.
- 2018-09-30: Operating Leases, Future Minimum Payments Due $4.90M.
- 2018-06-30: Operating Leases, Future Minimum Payments Due $2.16M.
- 2018-03-31: Operating Leases, Future Minimum Payments Due $2.33M.
| Period end | Operating Leases, Future Minimum Payments Due |
|---|---|
| 2018-12-31 | $3.66M 10-K · filed 2020-03-02 |
| 2018-09-30 | $4.90M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $2.16M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.33M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.49M 10-K · filed 2018-02-26 |
| 2017-09-30 | $2.66M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.83M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.83M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.97M 10-K · filed 2017-03-15 |
| 2016-09-30 | $2.11M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.25M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $2.40M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $2.49M 10-K · filed 2016-02-29 |
| 2015-03-31 | $45.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $114.00K 10-QT · filed 2015-02-17 |
| 2014-09-30 | $182.00K 10-K · filed 2014-12-22 |
| 2014-06-30 | $249.71K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $317.82K 10-Q · filed 2014-05-15 |